This Wall Street Journal article examines the latest trend to show China represents not only a fast-growing source of revenue for many multinational companies, but also a rising source of profit. AstraZeneca China was spotlighted as an example in the pharma sector.

--------------------------------------------------------------------------------------

This is not an article published by Pharma China, and please visit the following website link for the full text of the article.  The availability of the article is under the control of its publisher.  

http://online.wsj.com/article/SB119186674554852463.html?mod=googlenews_wsj

Note: By clicking on the above link, you will leave Pharma China Online. If you wish to return to this website, please click on "Back" button or log onto Pharma China Online again.